BRTH: Breathe BioMedical Inc. - Summary | Jitta

Breathe BioMedical Inc.

NASDAQ:BRTH

Notice
Stock data is unavailable or the company’s delisted.
Price
n/a
Loss Chance
51.1%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (0)
Recent Business Performance (6)
Financial Strength (15)
Return to Shareholders (0)
Competitive Advantage (3)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 62.40% in the last year
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
1.95
344.83%
1.95
344.83%
COMPANY DESCRIPTION
Breathe BioMedical Inc., a development-stage medical technology company, focuses on developing a breath test to detect early-stage breast cancer in women. Its test consists of SohnoXB Breath Sampler, a tabletop device that is used to collect alveolar breath from patients; a breath collection kit to store the breath sample during transportation to its laboratory facilities; a spectrometer to process breath samples; and a machine learning algorithm to analyze the breath spectral data from the spectrometer. Breathe BioMedical Inc. was formerly known as Picomole Inc. and changed its name to Breathe BioMedical Inc. in November 2023. The company was incorporated in 2005 and is based in Moncton, Canada.